Literature DB >> 27012039

A Panel of Oxidative Stress Markers in Parkinson's Disease.

A Bolner, R Micciolo, O Bosello, G P Nordera.   

Abstract

BACKGROUND: Oxidative stress may be the cause or effect of several pathogenetic processes such as neurodegenerative diseases. The aim of this paper was to evaluate the diagnostic efficacy in Parkinson's disease (PKD) of a panel of oxidative stress markers selected from the many proposed by the most recent literature.
METHODS: 23 molecules including both plasma and urinary oxidative markers such total radical oxygen species, homocysteine, biological antioxidant potential, glutathione, superoxide dismutase, uric acid, total bilirubin, iron, ferritin, coenzyme Q10, 3-nitrotyrosine, total lipoperoxides, 4-hydroxy-nonenal, and 8-hydroxy-deoxy-guanosine were determined both in PKD and aged control subjects. For each analyte and group, the respective reference intervals were determined. Statistical analysis was used to assess the existence of significant differences between intervals in order to indicate which markers can better characterize PKD and distinguish it from the control population.
RESULTS: Some parameters were different in both groups when compared to those observed in younger subjects, supporting the hypothesis that aging is associated with an increase of oxidative stress. A peculiar increase of oxidative damage on nucleic acids was found in PKD, as well as a less efficient turnover of the DNA and an increase of protein peroxidation.
CONCLUSIONS: Our results demonstrate that in PKD there is an increase of oxidative attack on nucleic acids and that the protein nitration is a characteristic phenomenon. These observations are in good agreement with the hypothesis that in PKD oxidative damage occurs that counter-regulatory systems attempt to balance, but inefficiently.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27012039     DOI: 10.7754/clin.lab.2015.150538

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  7 in total

1.  Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.

Authors:  Zhang Ping; Wu Xiaomu; Xie Xufang; Shao Liang
Journal:  Neurol Sci       Date:  2018-10-12       Impact factor: 3.307

Review 2.  Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  J Pers Med       Date:  2022-06-15

3.  Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.

Authors:  Xiumin Liu; Chenkang Wang; Weiwei Liu; Siaoyu Song; Jianing Fu; Toshihiko Hayashi; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Takashi Ikejima
Journal:  Neurochem Res       Date:  2021-06-07       Impact factor: 3.996

4.  Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Geidy E Serrano; Vellareddy Anantharam; Arthi Kanthasamy; Charles H Adler; Thomas G Beach; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 10.338

5.  Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration.

Authors:  Brina Snyder; Brent Shell; J Thomas Cunningham; Rebecca L Cunningham
Journal:  Physiol Rep       Date:  2017-05

6.  The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice.

Authors:  Pennapa Chonpathompikunlert; Phetcharat Boonruamkaew; Wanida Sukketsiri; Pilaiwanwadee Hutamekalin; Morakot Sroyraya
Journal:  BMC Complement Altern Med       Date:  2018-03-20       Impact factor: 3.659

7.  Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients.

Authors:  Zeeshan Hamid; Abdul Basit; Silvia Pontis; Fabrizio Piras; Francesca Assogna; Paola Bossù; Francesco Ernesto Pontieri; Alessandro Stefani; Gianfranco Spalletta; Pietro Franceschi; Angelo Reggiani; Andrea Armirotti
Journal:  Metabolomics       Date:  2019-05-03       Impact factor: 4.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.